UCLA POPULATION STUDIES OF CHRONIC OBSTRUCTIVE RESPIRATORY-DISEASE .1. METHODOLOGY AND COMPARISON OF LUNG-FUNCTION IN AREAS OF HIGH AND LOW POLLUTION

被引：49

|

作者：

DETELS, R

ROKAW, SN

COULSON, AH

TASHKIN, DP

SAYRE, JW

MASSEY, FJ

机构：

来源：

AMERICAN JOURNAL OF EPIDEMIOLOGY | 1979年 / 109卷 / 01期

关键词：

D O I：

10.1093/oxfordjournals.aje.a112658

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

收藏

页码：33 / 58

页数：26

相关论文

共 35 条

[31] Lung Function and Patient-Reported Outcomes Response to Glycopyrrolate (SEEBRI™ Neohaler®) in Chronic Obstructive Pulmonary Disease (COPD) Patients by Reversibility: Pooled Analysis of the GEM1 and GEM2 Studies
Bowling, A.
Goodin, T.
Price, B.
Ozol-Godfrey, A.
Sharma, S.
Sanjar, S.
Ohar, J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[32] Lung Function and Patient-Reported Outcomes Response to Indacaterol/Glycopyrrolate (UTIBRON™ Neohaler®) in Chronic Obstructive Pulmonary Disease (COPD) Patients by Reversibility: Pooled Analysis of the FLIGHT1 and FLIGHT2 Studies
Sharma, S.
Goodin, T.
Bowling, A.
Price, B.
Ozol-Godfrey, A.
Sanjar, S.
Ohar, J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[33] Chronic obstructive pulmonary disease: A comparison of estimates of health-related utility (EQ5D) from SF36 data alone, the SF36 plus lung function data, and the SF36 plus the St. George's Respiratory Questionnaire plus lung function data
Savani, V
Currie, CJ
Griffin, J
Loftus, J
McEwan, P
VALUE IN HEALTH, 2005, 8 (06) : A216 - A216
[34] Lung Function and Patient-Reported Outcomes Response to Indacaterol/Glycopyrrolate (UTIBRON™ Neohaler®) in Chronic Obstructive Pulmonary Disease (COPD) Patients by Smoking Status: Pooled Analysis of the FLIGHT1 and FLIGHT2 Studies
Sanjar, S.
Goodin, T.
Bowling, A.
Price, B.
Ozol-Godfrey, A.
Sharma, S.
Tashkin, D. P.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[35] Effect of Metabolic Syndrome Status on Lung Function and Patient- reported Outcomes in Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Indacaterol/Glycopyrrolate: Co-morbidity Analysis of the Phase 3 FLIGHT1 and 2 Studies
Carlin, Brian
Ferguson, Gary T.
Sanjar, Shahin
Sharma, Sanjay
Ozol-Godfrey, Ayca
Goodin, Thomas
CIRCULATION, 2018, 138

← 1 2 3 4 →